TPO and hypothyroidism: The RCT showed evidence that LLLT promoted the following: (a) an improvement in thyroid function, as indicated by the reduction in the dose of LT4 used to treat hypothyroidism; (b) a reduction in serum anti-TPO concentrations; and (c) improvement in the echogenicity, volume, and thyroid vascularization pattern in CDU [6, 7].